drugset / Trial / NCT00802139

Efficacy and Safety Study of Iron Sucrose and Oral Iron Acetyl-transferrin Hydroglycerin

NCT00802139 ↗

Phase 4 Completed 58 enrolled JW Pharmaceutical
RandomizedParallel-groupOpen-labelTreatment

Summary

multi-center, prospective, randomized, open-labeled, active-drug-controlled, two-parallel-group-comparison(venoferrun group vs Bolgre group)study

Timeline

Start
2008-02
Primary completion
2009-06
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bolgre Unknown 40 mg Oral
Subject Venoferrum Unknown — Intravenous